Get started
Author

Silvia Naneva

Observed names: Silvia V. Naneva, Silvia Y. Naneva
ORCID: 0000-0002-4659-3409
Observed ORCID: 0000-0002-4659-3409
OpenAlex ID: A5048213496
Lymphoepithelioma-like Carcinoma of the Breast Synchronous with a High-Grade Invasive Ductal Carcinoma and Ductal Carcinoma in Situ in a Different Quadrant of the Same Breast: A Case Report
2022 · Vasil Nanev, Silvia Naneva, et al. · Medicina · 4
PDF
STUDY OF THE IMMUNOLOGICAL MARKERS CD49d AND CD38 IN EARLY-STAGE B-CLL PATIENTS
2018 · Vanya Popova, Svetla Blazheva, et al. · Journal of IMAB - Annual Proceeding (Scientific Papers) · 3
Evaluation of Ki-67 index in breast cancer cases with intratumor heterogeneity
2024 · Hristo S. Milev, Vasil Nanev, et al. · Journal of Biomedical and Clinical Research · 1
PDF
Prognostic Biomarkers in Early-Stage B-CLL Patients
2017 · Vanya S. Popova, Svetla O. Blajeva, et al. · Journal of Biomedical and Clinical Research · 1
PDF
Real-world disease characteristics and frontline treatments used in chronic lymphocytic leukaemia in Bulgaria: An observational cohort study (DESCRIBE)
2026 · Vasko Graklanov, Atanas Radinoff, et al. · Journal of International Medical Research
Evaluation of cleaved caspase-3 and Ki-67 index on diagnostic biopsy in response to neoadjuvant chemotherapy in the context of post-treatment tumour ypT stage, ypN stage, grade, and molecular subtype
2024 · Vasil Nanev, Hristo Milev, et al. · Menopause Review/Przegląd Menopauzalny
PDF
Resistance to neoadjuvant chemotherapy in breast cancer with proven intratumoral heterogeneity: a clinical case
2022 · Vasil D. Nanev, Silvia V. Naneva, et al. · Oncology in Clinical Practice
PDF
Works count: 7
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type